Anti-DPH7 monoclonal antibody

Pre-made anti-DPH7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DPH7/DPH7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0723-Ab-1/ GM-Tg-hg-IP0723-Ab-2Anti-Human DPH7 monoclonal antibodyHuman
GM-Tg-rg-IP0723-Ab-1/ GM-Tg-rg-IP0723-Ab-2Anti-Rat DPH7 monoclonal antibodyRat
GM-Tg-mg-IP0723-Ab-1/ GM-Tg-mg-IP0723-Ab-2Anti-Mouse DPH7 monoclonal antibodyMouse
GM-Tg-cynog-IP0723-Ab-1/ GM-Tg-cynog-IP0723-Ab-2Anti-Cynomolgus/ Rhesus macaque DPH7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0723-Ab-1/ GM-Tg-felg-IP0723-Ab-2Anti-Feline DPH7 monoclonal antibodyFeline
GM-Tg-cang-IP0723-Ab-1/ GM-Tg-cang-IP0723-Ab-2Anti-Canine DPH7 monoclonal antibodyCanine
GM-Tg-bovg-IP0723-Ab-1/ GM-Tg-bovg-IP0723-Ab-2Anti-Bovine DPH7 monoclonal antibodyBovine
GM-Tg-equg-IP0723-Ab-1/ GM-Tg-equg-IP0723-Ab-2Anti-Equine DPH7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0723-Ab-1/ GM-Tg-hg-IP0723-Ab-2; GM-Tg-rg-IP0723-Ab-1/ GM-Tg-rg-IP0723-Ab-2;
GM-Tg-mg-IP0723-Ab-1/ GM-Tg-mg-IP0723-Ab-2; GM-Tg-cynog-IP0723-Ab-1/ GM-Tg-cynog-IP0723-Ab-2;
GM-Tg-felg-IP0723-Ab-1/ GM-Tg-felg-IP0723-Ab-2; GM-Tg-cang-IP0723-Ab-1/ GM-Tg-cang-IP0723-Ab-2;
GM-Tg-bovg-IP0723-Ab-1/ GM-Tg-bovg-IP0723-Ab-2; GM-Tg-equg-IP0723-Ab-1/ GM-Tg-equg-IP0723-Ab-2
Products NameAnti-DPH7 monoclonal antibody
Formatmab
Target NameDPH7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DPH7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0723-Ag-1Recombinant multi-species DPH7/ C9orf112/ RRT2 protein


    Target information

    Target IDGM-IP0723
    Target NameDPH7
    Gene ID92715,67228,296550,703764,100688792,101086607,101907584,100147491
    Gene Symbol and Synonyms2810443J12Rik,C9orf112,DPH7,RGD1304868,RRT2,WDR85
    Uniprot AccessionQ9BTV6
    Uniprot Entry NameDPH7_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000148399
    Target ClassificationN/A

    The target: DPH7, gene name: DPH7, also named as C9orf112, RRT2, WDR85. Diphthamide is a post-translationally modified histidine residue present in elongation factor 2, and is the target of diphtheria toxin. This gene encodes a protein that contains a WD-40 domain, and is thought to be involved in diphthamide biosynthesis. A similar protein in yeast functions as a methylesterase, converting methylated diphthine to diphthine, which can then undergo amidation to produce diphthamide. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.